iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/31401022
Efficacy of hemostatic powders in upper gastrointestinal bleeding: A systematic review and meta-analysis - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Dec;51(12):1633-1640.
doi: 10.1016/j.dld.2019.07.001. Epub 2019 Aug 7.

Efficacy of hemostatic powders in upper gastrointestinal bleeding: A systematic review and meta-analysis

Antonio Facciorusso  1 , Marcelo Straus Takahashi  2 , Ceren Eyileten Postula  3 , Vincenzo Rosario Buccino  4 , Nicola Muscatiello  4
Affiliations
Meta-Analysis

Efficacy of hemostatic powders in upper gastrointestinal bleeding: A systematic review and meta-analysis

Antonio Facciorusso et al. Dig Liver Dis. 2019 Dec.

Abstract

Background: There is limited evidence on the efficacy of hemostatic powders in the management of upper gastrointestinal bleeding.

Aims: Provide a pooled estimate of the efficacy and safety profile of hemostatic powders in digestive endoscopy.

Methods: A computerized bibliographic search on the main databases was performed through December 2018. Pooled effects were calculated using a random-effects model. The primary outcome was immediate hemostasis rate. Secondary outcomes were rebleeding rate (either at 7 and 30 days), bleeding-related mortality, and all-cause mortality rate.

Results: A total of 24 studies, of which three were randomized-controlled trials, with 1063 patients were included in the meta-analysis. Immediate hemostasis was achieved in 95.3% (93.3%-97.3%) of patients, with no difference based on treatment strategy, hemostatic agent used, bleeding etiology. Success rate was slightly lower in spurting bleeding (91.9%). Hemostatic powders showed similar efficacy as compared to conventional endoscopic therapy (odds ratio: 0.84, 0.06-11.47; p = 0.9). Thirty-day rebleeding rate was 16.9% (9.8%-24%) with no difference in comparison to other endoscopic treatments (odds ratio 1.59, 0.35-7.21; p = 0.55). All-cause and bleeding-related mortality rates were 7.6% (4%-10.8%) and 1.4% (0.5%-2.4%), respectively.

Conclusion: Novel hemostatic powders represent a user-friendly and effective tool in the management of upper gastrointestinal bleeding.

Keywords: EndoClot; Hemospray; Hemostasis; Tumor; Ulcer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

LinkOut - more resources